# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-25-011909
Filing Date
2025-09-08
Accepted
2025-09-08 07:45:20
Documents
35
Period of Report
2025-09-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | apre-20250908x8k.htm iXBRL | 8-K | 38864
2 | EX-99.1 | apre-20250908xex99d1.htm | EX-99.1 | 34802
3 | GRAPHIC | apre-20250908xex99d1g001.jpg | GRAPHIC | 133116
4 | GRAPHIC | apre-20250908xex99d1g002.jpg | GRAPHIC | 258864
5 | GRAPHIC | apre-20250908xex99d1g003.jpg | GRAPHIC | 97755
6 | GRAPHIC | apre-20250908xex99d1g004.jpg | GRAPHIC | 115683
7 | GRAPHIC | apre-20250908xex99d1g005.jpg | GRAPHIC | 169896
8 | GRAPHIC | apre-20250908xex99d1g006.jpg | GRAPHIC | 89374
9 | GRAPHIC | apre-20250908xex99d1g007.jpg | GRAPHIC | 171524
10 | GRAPHIC | apre-20250908xex99d1g008.jpg | GRAPHIC | 113437
11 | GRAPHIC | apre-20250908xex99d1g009.jpg | GRAPHIC | 75619
12 | GRAPHIC | apre-20250908xex99d1g010.jpg | GRAPHIC | 172294
13 | GRAPHIC | apre-20250908xex99d1g011.jpg | GRAPHIC | 179367
14 | GRAPHIC | apre-20250908xex99d1g012.jpg | GRAPHIC | 141712
15 | GRAPHIC | apre-20250908xex99d1g013.jpg | GRAPHIC | 88680
16 | GRAPHIC | apre-20250908xex99d1g014.jpg | GRAPHIC | 133397
17 | GRAPHIC | apre-20250908xex99d1g015.jpg | GRAPHIC | 90497
18 | GRAPHIC | apre-20250908xex99d1g016.jpg | GRAPHIC | 161677
19 | GRAPHIC | apre-20250908xex99d1g017.jpg | GRAPHIC | 141370
20 | GRAPHIC | apre-20250908xex99d1g018.jpg | GRAPHIC | 98800
21 | GRAPHIC | apre-20250908xex99d1g019.jpg | GRAPHIC | 166684
22 | GRAPHIC | apre-20250908xex99d1g020.jpg | GRAPHIC | 197251
23 | GRAPHIC | apre-20250908xex99d1g021.jpg | GRAPHIC | 149609
| Complete submission text file | 0001558370-25-011909.txt |  | 4234660

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
24 | EX-101.SCH | apre-20250908.xsd | EX-101.SCH | 4087
25 | EX-101.DEF | apre-20250908_def.xml | EX-101.DEF | 2842
26 | EX-101.LAB | apre-20250908_lab.xml | EX-101.LAB | 16591
27 | EX-101.PRE | apre-20250908_pre.xml | EX-101.PRE | 10901
37 | EXTRACTED XBRL INSTANCE DOCUMENT | apre-20250908x8k_htm.xml | XML | 4631

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 251298589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)